)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Bumrungrad Hospital
Bumrungrad Hospital (BH) investor relations material
Bumrungrad Hospital Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary20 Aug, 2026
Executive summary
Q2 2026 revenue grew 3.8% year-over-year to THB 6,278 million, led by strong international patient demand, especially from the Middle East, Myanmar, U.S., and U.K., offsetting softness in the Thai market and Cambodia.
Non-Thai patient revenue accounted for 66% of total, with Middle East patients contributing 23%.
Net profit for Q2 2026 was THB 1,910 million, with a net profit margin of about 30.4%.
Interim dividend doubled to THB 4 per share, payout scheduled for September 2026.
Financial highlights
Q2 2026 total revenue: THB 6,278 million (+2.9% YoY); 1H 2026: THB 12,532 million (+1.8% YoY).
Q2 EBITDA: THB 2,599 million (+2.4% YoY), margin 41.4%; 1H EBITDA: THB 5,054 million (+3.7% YoY), margin 40.3%.
Q2 net profit: THB 1,910 million (+1.7% YoY), margin 30.4%; 1H net profit: THB 3,710 million (+2.4% YoY), margin 29.4%.
Basic EPS for Q2 2026 was THB 2.38; for six months, THB 4.63.
Net debt to EBITDA: -0.4x; liability to asset ratio: 16.4%.
Outlook and guidance
Q3 2026 revenue growth guidance: +/-3% top-line, with continued focus on international patient growth and service excellence.
Optimistic about future earnings growth, with potential upside from Kuwait, Cambodia, Iraq, and Bangladesh as geopolitical and visa issues resolve.
No major growth from Cambodia factored into Q3 guidance.
Management is evaluating the impact of new accounting standards effective in 2028.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bumrungrad Hospital
- Revenue and profit advanced, alongside higher overdue receivables and major investment commitments.BH
Q3 2026 Pre recorded - 9M net profit reached Baht 5,788 million as dividends paid totaled Baht 10,344 million.BHQ3 2026 (Q&A)
- Record FY2023 earnings, led by international patients and strong insurance growth.BHQ4 2023
- Q1 2026 saw revenue and profit growth, strong margins, and rising international patient revenue.BHQ1 2026 (Q&A)
- Record EBITDA margin and strong international patient growth drove Q1 2026 results.BHQ1 2026 Pre-recorded
- Record EBITDA margin and special dividend highlight a resilient Q4 amid international growth.BHQ4 2025
- Q3 2025 delivered record margins and profit, led by international patient growth and expansion.BHQ3 2025
- Record profit growth and margins in Q2 and H1 2024, with a record interim dividend declared.BHQ2 2024
- EPS and net profit rose 11% in 2024, with record margins and a proposed record dividend.BHQ4 2024
Next Bumrungrad Hospital earnings date
Q3 2026 Pre recorded16 Nov, 2026
Bumrungrad Hospital
Next Bumrungrad Hospital earnings date
Q3 2026 Pre recorded16 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Bumrungrad Hospital Public Company Limited is a Thai healthcare provider known for offering a comprehensive range of medical services and treatments. The hospital operates a large, internationally accredited medical facility in Bangkok, catering to both local and international patients. Bumrungrad provides specialized healthcare services across multiple disciplines, including cardiology, oncology, orthopedics, and neurology, and is equipped with advanced diagnostic and treatment technologies. The company is headquartered in Bangkok, Thailand, and its shares are listed on the Stock Exchange of Thailand.